Akoustis Technologies Inc diskutieren
Akoustis Technologies Inc
WKN: A2DTX6 / Symbol: AKTS / Name: Akoustis Technologies Inc / Aktie / Software & Informationsdienstleistungen / Small Cap /
0,001 €
-
Aktis Oncology (AKTS) had its price target raised by HC Wainwright from $30.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for AKTS provided by MarketBeat
Aktis Oncology (AKTS) is now covered by William Blair. They set an "outperform" rating on the stock.
Ratings data for AKTS provided by MarketBeat
Aktis Oncology (AKTS) had its "buy" rating reaffirmed by HC Wainwright.
Ratings data for AKTS provided by MarketBeat
Aktis Oncology (AKTS) had its price target raised by JPMorgan Chase & Co. from $30.00 to $33.00. They now have an "overweight" rating on the stock.
Ratings data for AKTS provided by MarketBeat
Aktis Oncology (AKTS) was downgraded by Wall Street Zen from "hold" to "sell".
Ratings data for AKTS provided by MarketBeat
Aktis Oncology (AKTS) is now covered by Wedbush. They set an "outperform" rating and a $35.00 price target on the stock.
Ratings data for AKTS provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Whitehorse Finance Inc. diskutieren